The Direct Anterior Approach to Primary Total Hip Replacement: Radiological Analysis in Comparison to Other Approaches.
Artur StolarczykMagda StolarczykPiotr StępińskiMonika K DorocińskaMaciej ŚwierczJakub SzymczakKrystian ŻarnovskyAlbert ŻuchniewiczBartosz Michał MaciągPublished in: Journal of clinical medicine (2021)
Total hip arthroplasty (THA) is currently considered the most effective treatment for end-stage hip osteoarthritis (OA). The surgery can be performed via a number of different approaches, including direct anterior (DAA; Smith-Petersen; Hueter), anterolateral (ALA; Watson-Jones), direct lateral (LA; Bauer), posterior (PA; Kocher-Langenbeck), and posterolateral (PLA). There is still a dispute over the optimal technique. The aim of this systematic review was to assess how different surgical approaches toward a THA influence the prosthesis elements' positioning. We conducted a literature search of Scopus, ScienceDirect, PubMed, Embase, and The Cochrane Library. We evaluated studies in terms of the first author's name, country, publication year, type of surgical approach being compared to the direct anterior approach, any significant differences at baseline, sample size, and radiographic analysis. A subanalysis of each approach in comparison to the DAA revealed differences in terms of all analyzed implant positioning radiographic parameters. There is still an insufficient number of randomized controlled studies that include radiological analyses comparing THRs (total hip replacements) performed using DAA with other approaches. Implant placement is a crucial step during a THR and surgeons must be aware that the approach they use might impact their judgment on angles and spaces inside the joint and thus alter the implant positioning.
Keyphrases
- total hip
- systematic review
- total knee arthroplasty
- total hip arthroplasty
- minimally invasive
- soft tissue
- rheumatoid arthritis
- randomized controlled trial
- double blind
- single cell
- quality improvement
- coronary artery disease
- case control
- placebo controlled
- phase iii
- coronary artery bypass
- smoking cessation
- phase ii
- data analysis